n South African Law Journal - Twelve years after Canada's access to medicines regime : should South Africa follow the path?




On 30 August 2003, the World Trade Organization decided that eligible countries without manufacturing capacities would be allowed to import generic drugs once they had been issued with a compulsory licence from an exporter country. Canada was the first country to implement this decision in its patent law and subsequently to apply it. Considering the fact that improving drug accessibility is a priority in sub-Saharan Africa, it is relevant for countries with manufacturing capacities, like South Africa, to consider implementing the August 30th decision into their legislation. This mechanism represents an opportunity for South Africa to develop its pharmaceutical industry and to increase drug accessibility in Africa. In exploring this option, the Canadian drug exportation mechanism could serve as a model for legislation in South Africa. In this article we review the Canadian experience, including the weaknesses of the Canadian platform. Based on lessons from this review, we suggest that South Africa should consider implementing a new drug exportation mechanism in its national patent law in order to rebuild its pharmaceutical manufacturing capacities and to improve access to drugs in Africa. In essence, by supplying sub-Saharan African countries, and thus using the compulsory licensing mechanism created following the Pretoria lawsuits, South Africa would close the loop.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error